• Login
    View Item 
    •   IIMA Institutional Repository Home
    • Faculty Publications (Bibliographic)
    • Journal Articles
    • View Item
    •   IIMA Institutional Repository Home
    • Faculty Publications (Bibliographic)
    • Journal Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    When the big one came: A natural experiment on demand shock and market structure in India’s Influenza Vaccine markets

    Thumbnail
    View/Open
    when the big one came.pdf (733.2Kb)
    Date
    2018
    Author
    Adbi, A.
    Chatterjee, C.
    Drev, M.
    Mishra, A.
    Metadata
    Show full item record
    Abstract
    This study examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines in India, and exploiting the 2009– 10 global H1N1 pandemic as an exogenous demand shock, we provide evidence of heterogeneous responses to the shock by domestic and multinational vaccine manufacturers in the influenza vaccine market relative to our control group of all other vaccine markets. We find that such a shock results in a reversal of the market structure for influenza vaccines in India, with a decline in the market share of multinational vaccine manufacturers and significant gains in the market share of domestic vaccine manufacturers. This reversal of the market structure is driven by increased efforts at new product introduction among domestic vaccine manufacturers, the effects of which persist even after the pandemic has ended. Our results remain robust to the use of alternative controls, synthetic control method, coarsened exact matching method, and other relevant estimation methodologies. These results provide new evidence on the role of a pandemic-induced demand shock in the context of an emerging economy by creating differential incentives for domestic and multinational vaccine manufacturers to bring new products to market. We also conduct additional analysis to explore the impact of targeted policy instruments on the new product introduction efforts of domestic vaccine manufacturers. Finally, we discuss the implications of our findings and offer insights into the role of policy on pandemic preparedness in emerging markets facing adverse welfare effects from pandemics.
    URI
    http://hdl.handle/11718/1867
    http://hdl.handle.net/11718/22916
    Collections
    • Journal Articles [3738]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of IIMA Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV